Biocryst Pharmaceuticals
Clinical trials sponsored by Biocryst Pharmaceuticals, explained in plain language.
-
New hope for kids with rare swelling disorder: daily pill may prevent attacks
Disease control OngoingThis study tests a daily medication called berotralstat to prevent sudden swelling attacks in children aged 2 to 12 with hereditary angioedema (HAE). About 29 children will take the pill to see how it works in their bodies and if it is safe. The goal is to find the right dose to …
Phase: PHASE3 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:51 UTC
-
New eye injection shows early promise for diabetes-related vision loss
Disease control OngoingThis early-phase study tests a single injection of avoralstat into the eye for people with diabetic macular edema, a condition that causes vision loss. Nine adults with diabetes and center-involved swelling in the retina will be monitored for safety and any signs of improvement i…
Phase: PHASE1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
Study offers ongoing HAE treatment access for prior trial participants
Disease control ENROLLING_BY_INVITATIONThis study gives people with hereditary angioedema (HAE) who were in earlier berotralstat trials continued access to the medication. About 139 participants will receive the drug and be monitored for side effects and safety. The goal is to keep providing treatment while gathering …
Phase: PHASE3 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated May 05, 2026 11:53 UTC